Dual-phase dual-energy CT in patients with lung cancer: assessment of the additional value of iodine quantification in lymph node therapy response

[11] Gelderblom H(2012)Virtual non-contrast in second-generation, dual-energy computed tomography: reliability of attenuation values Eur J Radiol 81 e398-e405

[12] Bloem JL(2012)Quantitative dual energy CT measurements in rabbit VX2 liver tumors: comparison to perfusion CT measurements and histopathological findings Eur J Radiol 81 1766-1775

[13] Nathan PD(2011)Liver metastases on quantitative color mapping of the arterial enhancement fraction from multiphasic CT scans: evaluation of the hemodynamic features and correlation with the chemotherapy response Eur J Radiol 80 e278-e283

[14] Vinayan A(2014)Comparison of dual-energy CT-derived iodine content and iodine overlay of normal, inflammatory and metastatic squamous cell carcinoma cervical lymph nodes Eur Radiol 24 574-580

[15] Stott D(2012)Dual energy CT in patients treated with anti-angiogenic agents for non-small cell lung cancer: new method of monitoring tumor response? Korean J Radiol 13 702-710

[16] Juttla J(2013)Dual-energy CT in the assessment of mediastinal lymph nodes: comparative study of virtual non-contrast and true non-contrast images Korean J Radiol 14 532-539

[17] Goh V(2013)Monitoring targeted therapy using dual-energy CT: semi-automatic RECIST plus supplementary functional information by quantifying iodine uptake of melanoma metastases Cancer Imaging 13 306-313

[18] Walker CM(2012)Correlation between dynamic CT findings and pathological prognostic factors of small lung adenocarcinoma Cancer Imaging 12 187-193

[19] Chung JH(1997)Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT Radiology 205 49-53

[20] Abbott GF(2009)Quantitative CT colour mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma Radiology 250 425-434

[11] Gelderblom H(2012)Virtual non-contrast in second-generation, dual-energy computed tomography: reliability of attenuation values Eur J Radiol 81 e398-e405

[12] Bloem JL(2012)Quantitative dual energy CT measurements in rabbit VX2 liver tumors: comparison to perfusion CT measurements and histopathological findings Eur J Radiol 81 1766-1775

[13] Nathan PD(2011)Liver metastases on quantitative color mapping of the arterial enhancement fraction from multiphasic CT scans: evaluation of the hemodynamic features and correlation with the chemotherapy response Eur J Radiol 80 e278-e283

[14] Vinayan A(2014)Comparison of dual-energy CT-derived iodine content and iodine overlay of normal, inflammatory and metastatic squamous cell carcinoma cervical lymph nodes Eur Radiol 24 574-580

[15] Stott D(2012)Dual energy CT in patients treated with anti-angiogenic agents for non-small cell lung cancer: new method of monitoring tumor response? Korean J Radiol 13 702-710

[16] Juttla J(2013)Dual-energy CT in the assessment of mediastinal lymph nodes: comparative study of virtual non-contrast and true non-contrast images Korean J Radiol 14 532-539

[17] Goh V(2013)Monitoring targeted therapy using dual-energy CT: semi-automatic RECIST plus supplementary functional information by quantifying iodine uptake of melanoma metastases Cancer Imaging 13 306-313

[18] Walker CM(2012)Correlation between dynamic CT findings and pathological prognostic factors of small lung adenocarcinoma Cancer Imaging 12 187-193

[19] Chung JH(1997)Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT Radiology 205 49-53

[20] Abbott GF(2009)Quantitative CT colour mapping of the arterial enhancement fraction of the liver to detect hepatocellular carcinoma Radiology 250 425-434